what to expect when switching from semaglutide to tirzepatide How to Switch from Tirzepatide

Realistic expectations are essential, as outcomes can vary depending on skin type, lifestyle, dosage, and individual response

Compounding and the FDA: Questions and answers, Food and Drug Administration (2024) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2024) Mounjaro, DailyMed (2024) FDAs concerns with unapproved GLP-1 drugs used for weight loss, Food and Drug Administration (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

Report any suspected side effects to your healthcare professional and consider using the MHRA Yellow Card Scheme

We monitor throughout treatment

This includes: Primary Care Physicians (PCPs) Endocrinologists Internists Nurse Practitioners (NPs) Physician Assistants (PAs) Obesity Specialists/Bariatricians Telemedicine Providers Patients interested in Zepbound should consult their healthcare provider to discuss whether it is appropriate for their weight management needs, considering their overall health profile and any potential contraindications